The Venture Codex Logo

The Venture Codex

Overview

Investment syndicate for early-stage psychedelics companies.

Founded

2020

Deals · 12mo

1

Stage focus

Seed
Series A

Geographic focus

Australia
Ireland
Israel
United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

11rounds
NAMEDATESIZE
Remepy
Aug 2026Participated
$36 MSeries A
Aerska
Oct 2025Participated
$21 MSeed
Jimini Health
Nov 2024Participated
$8 MSeed
Neurode
Sep 2024Participated
$4 MSeed
Ancilia Biosciences
Aug 2024Participated
$4 MOther Equity
Remepy
May 2024Participated
$10 MSeed
Motif Neurotech
Jan 2024Participated
$19 MSeries A
Journey Clinical
Jan 2023Participated
$9 MSeries A
Freedom Biosciences
Aug 2022Participated
$11 MSeed
Delix Therapeutics
Sep 2021Participated
$70 MSeries A
Journey Clinical
Sep 2021Participated
$3 MSeed
Remepy
Aug 2026Participated
$36 MSeries A
Aerska
Oct 2025Participated
$21 MSeed
Jimini Health
Nov 2024Participated
$8 MSeed
Neurode
Sep 2024Participated
$4 MSeed
Ancilia Biosciences
Aug 2024Participated
$4 MOther Equity
Remepy
May 2024Participated
$10 MSeed
Motif Neurotech
Jan 2024Participated
$19 MSeries A
Journey Clinical
Jan 2023Participated
$9 MSeries A
Freedom Biosciences
Aug 2022Participated
$11 MSeed
Delix Therapeutics
Sep 2021Participated
$70 MSeries A
Journey Clinical
Sep 2021Participated
$3 MSeed
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

PsyMed Ventures: 11 funding rounds are recorded in the selected participation categories.All available history.
PsyMed Ventures: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed06
Series A04
Other Equity01

Monthly Deal Activity

PsyMed Ventures: 11 deals are recorded across 62 months.All available history.
PsyMed Ventures: 11 deals are recorded across 62 months. All available history
MonthDeals
Sep '212
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '241
Sep '241
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

PsyMed Ventures: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

PsyMed Ventures: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11
Marketing & Advertising1
AI & Machine Learning1

Deal Size Distribution

PsyMed Ventures: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

PsyMed Ventures: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M2
$10M-$25M4
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

PsyMed Ventures: United States has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

PsyMed Ventures: United States has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
United States7
Israel2
Europe1
Australia1
PsyMed Ventures: 20 co-investors are shown, with Palo Santo sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

PsyMed Ventures: Led accounts for 0% and participating for 100% of round participation.All available history.
PsyMed Ventures: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating11100%
PsyMed Ventures: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
PsyMed Ventures: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Caitlin Ner

Chief of Staff

Garri Zmudze

Venture Partner

Greg Kubin

Founder

Matias Serebrinsky

Co-founder and General Partner